Annual Congress Berlin 2001

Saturday, 22.09.2001
Sunday, 23.09.2001
Monday, 24.09.2001
Tuesday, 25.09.2001
Wednesday, 26.09.2001

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 18: Suppl. 33, abstract number.

Material from 2001:

3025 Abstracts

Material from 2001: Show

Emerging developments in lung transplantation

Oral Presentation
Chairs: W. Klepetko (Wien, Austria), C. Bravo Masgoret (Barcelona, Spain)

Download all media

Advantage of retrograde flush perfusion with low potassium dextran solution for preservation in lung transplantation J. M. Hohlfeld, M. Strueber, T. Kofides, G. Warnecke, S. P. Sommer, J. Niedermeyer, A. Haverich, H. Fabel (Hannover, Germany)
Lung transplantation of ventilator-dependent patients - analysis of survival and graft function in 27 patients J. Niedermeyer, M. Strueber, M. M. Hoeper, M. Anssar, A. Haverich, H. Fabel (Hannover, Germany)
*A single centre prospective, randomized trial of basiliximab versus* ATG induction therapy in lung transplantation** B. Senn, A. Dutly, R. Naef, R. Speich, W. Weder, A. Boehler (Zurich, Switzerland)
³He-MRI in lung transplant recipients (LTR) in correlation with lung function tests J. Lill, H. U. Kauczor, B. Eberle, N. Weiler, K. Markstaller, R. Buhl, M. Thelen (Mainz, Germany)
Influenza vaccination after lung transplantation: does nasal application improve immunological response? M. Hofer, W. Bossart, R. Naef, R. Speich, E. W. Russi, A. Boehler (Zurich, Switzerland)
Exhaled nitric oxide (eNO) and lung transplantation (LTx): impact of the native lung? G. M. Verleden, L. Dupont, M. Delcroix, B. Buyse, J. Vanhaecke, D. Van Raemdonck, T. Lerut, M. Demedts (Leuven, Belgium)
Elevated levels of chemokines in bronchoalveolar lavage fluid as diagnostic markers for predicting the development of post-transplant obliterative bronchiolitis M. Reynaud-Gaubert, C. Farnarier, X. Thirion, P. Thomas, M. Badier, R. Giudicelli, P. Fuentes (Marseille, France)